EQNVX
Price
$23.64
Change
+$0.19 (+0.81%)
Updated
Sep 4 closing price
Net Assets
674.39M
RMEBX
Price
$60.71
Change
+$0.28 (+0.46%)
Updated
Sep 4 closing price
Net Assets
109.46B
Interact to see
Advertisement

EQNVX vs RMEBX

Header iconEQNVX vs RMEBX Comparison
Open Charts EQNVX vs RMEBXBanner chart's image
MFS Equity Income R6
Price$23.64
Change+$0.19 (+0.81%)
VolumeN/A
Net Assets674.39M
American Funds American Mutual R2E
Price$60.71
Change+$0.28 (+0.46%)
VolumeN/A
Net Assets109.46B
EQNVX vs RMEBX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
EQNVX vs. RMEBX commentary
Sep 09, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is EQNVX is a Buy and RMEBX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RMEBX has more cash in the bank: 109B vs. EQNVX (674M). EQNVX pays higher dividends than RMEBX: EQNVX (2.15) vs RMEBX (1.09). EQNVX was incepted earlier than RMEBX: EQNVX (13 years) vs RMEBX (11 years). RMEBX (1.07) is less costly to investors than EQNVX (0.63). EQNVX is a more actively managed with annual turnover of: 45.00 vs. RMEBX (31.00). EQNVX has a lower initial minimum investment than RMEBX: EQNVX (0) vs RMEBX (250). EQNVX annual gain was more profitable for investors over the last year : 9.70 vs. RMEBX (7.57). EQNVX return over 5 years is better than : 59.63 vs. RMEBX (55.29).
EQNVXRMEBXEQNVX / RMEBX
Total Expense Ratio0.551.0751%
Annual Report Gross Expense Ratio0.631.0759%
Fund Existence13 years11 years-
Gain YTD12.83911.308114%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets674M109B1%
Annual Yield % from dividends2.151.09197%
Returns for 1 year9.707.57128%
Returns for 3 years37.8731.59120%
Returns for 5 years59.6355.29108%
Returns for 10 years116.3589.40130%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CTMX2.280.18
+8.57%
CytomX Therapeutics
ICFI95.211.03
+1.09%
ICF International
ANSCU10.82N/A
N/A
Agriculture & Natural Solutions Acquisition Corp
KMX60.70-0.25
-0.41%
CarMax
SMXT1.14-0.03
-2.56%
Solarmax Technology